These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17689677)

  • 21. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
    Nishikawa N; Kimura Y; Okita K; Zembutsu H; Furuhata T; Katsuramaki T; Kimura S; Asanuma H; Hirata K
    J Hepatobiliary Pancreat Surg; 2006; 13(4):327-35. PubMed ID: 16858545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.
    Raut CP; Cleary KR; Staerkel GA; Abbruzzese JL; Wolff RA; Lee JH; Vauthey JN; Lee JE; Pisters PW; Evans DB
    Ann Surg Oncol; 2006 Apr; 13(4):582-94. PubMed ID: 16523362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraductal papillary mucinous tumors of the pancreas. Surgical treatment: at what point should we stop?
    Salvia R; Bassi C; Falconi M; Serini P; Crippa S; Capelli P; Pederzoli P
    JOP; 2005 Jan; 6(1 Suppl):112-7. PubMed ID: 15650295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive carcinoma derived from intraductal papillary mucinous carcinoma of the pancreas.
    Nakagohri T; Konishi M; Inoue K; Tanizawa Y; Kinoshita T
    Hepatogastroenterology; 2004; 51(59):1480-3. PubMed ID: 15362782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery?
    Jang JY; Kim SW; Ahn YJ; Yoon YS; Choi MG; Lee KU; Han JK; Kim WH; Lee YJ; Kim SC; Han DJ; Kim YI; Choi SH; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee KB; Kim YC; Lee KS; Kim MW; Kim HJ; Kim HJ; Park YH
    Ann Surg Oncol; 2005 Feb; 12(2):124-32. PubMed ID: 15827792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
    Schnelldorfer T; Sarr MG; Nagorney DM; Zhang L; Smyrk TC; Qin R; Chari ST; Farnell MB
    Arch Surg; 2008 Jul; 143(7):639-46; discussion 646. PubMed ID: 18645105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas.
    Ohtsuka T; Kono H; Tanabe R; Nagayoshi Y; Mori Y; Sadakari Y; Takahata S; Oda Y; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M
    Am J Surg; 2012 Jul; 204(1):44-8. PubMed ID: 21996346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas.
    Falconi M; Salvia R; Bassi C; Zamboni G; Talamini G; Pederzoli P
    Br J Surg; 2001 Mar; 88(3):376-81. PubMed ID: 11260102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical features and prognosis of intraductal papillary mucinous neoplasms of pancreas: analysis of 38 cases].
    Lou WH; Wang DS; Ji Y; Xu XF; Kuang TT; Ni XL; Wu WC; Jin DY
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):947-50. PubMed ID: 16759531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
    Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifocal pancreatic ductal adenocarcinomas concomitant with intraductal papillary mucinous neoplasms of the pancreas detected by intraoperative pancreatic juice cytology. A case report.
    Mori Y; Ohtsuka T; Tsutsumi K; Yasui T; Sadakari Y; Ueda J; Takahata S; Nakamura M; Tanaka M
    JOP; 2010 Jul; 11(4):389-92. PubMed ID: 20601817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advantage of pancreaticogastrostomy in detecting recurrent intraductal papillary mucinous carcinoma in the remnant pancreas: a case of successful re-resection after pancreaticoduodenectomy.
    Tomimaru Y; Ishikawa O; Ohigashi H; Eguchi H; Yamada T; Sasaki Y; Miyashiro I; Ohue M; Yano M; Uehara H; Nakaizumi A; Imaoka S
    J Surg Oncol; 2006 May; 93(6):511-5. PubMed ID: 16615155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience.
    Yang AD; Melstrom LG; Bentrem DJ; Ujiki MB; Wayne JD; Strouch M; Bell RH; Rao SM; Talamonti MS
    Surgery; 2007 Oct; 142(4):529-34; discussion 534-7. PubMed ID: 17950345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
    Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
    Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent invasive intraductal papillary mucinous carcinoma of the pancreas mimicking pott disease: review of the literature.
    Corvera CU; Dunnican WJ; Blumgart LH; D'Angelica M
    Pancreas; 2006 Apr; 32(3):321-4. PubMed ID: 16628089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type.
    Takasu N; Kimura W; Moriya T; Hirai I; Takeshita A; Kamio Y; Nomura T
    Pancreas; 2010 Jul; 39(5):604-10. PubMed ID: 20124938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas.
    Kloek JJ; van der Gaag NA; Erdogan D; Rauws EA; Busch OR; Gouma DJ; ten Kate FJ; van Gulik TM
    Hum Pathol; 2011 Jun; 42(6):824-32. PubMed ID: 21292296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity.
    Sohn TA; Yeo CJ; Cameron JL; Iacobuzio-Donahue CA; Hruban RH; Lillemoe KD
    Ann Surg; 2001 Sep; 234(3):313-21; discussion 321-2. PubMed ID: 11524584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Middle-preserving pancreatectomy: an interesting procedure for pancreas-sparing resection.
    Sperti C; Polizzi ML; Moro M; Beltrame V; Pedrazzoli S
    JOP; 2010 May; 11(3):258-61. PubMed ID: 20442523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasive IPMN and MCN: same organ, different outcomes?
    Kargozaran H; Vu V; Ray P; Bagaria S; Steen S; Ye X; Gagandeep S
    Ann Surg Oncol; 2011 Feb; 18(2):345-51. PubMed ID: 20809175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.